Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
With
Otsuka America Pharmaceutical
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with schizophrenia treated with clozapine (200-900 mg/day), who gained at least 2.5 kg while on clozapine.
You may not be if
Patients known to be allergic to aripiprazole
Hospitalized patients
Patients who have previously received study medication in an aripiprazole clinical study or who have participated in any clinical trial with an investigational agent within the past month.
Clareo Health | A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
